1. Home
  2. SLS vs BRCC Comparison

SLS vs BRCC Comparison

Compare SLS & BRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • BRCC
  • Stock Information
  • Founded
  • SLS 2012
  • BRCC 2014
  • Country
  • SLS United States
  • BRCC United States
  • Employees
  • SLS N/A
  • BRCC N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • BRCC Beverages (Production/Distribution)
  • Sector
  • SLS Health Care
  • BRCC Consumer Staples
  • Exchange
  • SLS Nasdaq
  • BRCC Nasdaq
  • Market Cap
  • SLS 185.3M
  • BRCC 186.6M
  • IPO Year
  • SLS N/A
  • BRCC N/A
  • Fundamental
  • Price
  • SLS $1.85
  • BRCC $1.62
  • Analyst Decision
  • SLS Strong Buy
  • BRCC Strong Buy
  • Analyst Count
  • SLS 1
  • BRCC 4
  • Target Price
  • SLS $7.00
  • BRCC $2.75
  • AVG Volume (30 Days)
  • SLS 1.9M
  • BRCC 583.5K
  • Earning Date
  • SLS 11-12-2025
  • BRCC 11-03-2025
  • Dividend Yield
  • SLS N/A
  • BRCC N/A
  • EPS Growth
  • SLS N/A
  • BRCC N/A
  • EPS
  • SLS N/A
  • BRCC N/A
  • Revenue
  • SLS N/A
  • BRCC $388,893,000.00
  • Revenue This Year
  • SLS N/A
  • BRCC $4.29
  • Revenue Next Year
  • SLS N/A
  • BRCC $11.89
  • P/E Ratio
  • SLS N/A
  • BRCC N/A
  • Revenue Growth
  • SLS N/A
  • BRCC N/A
  • 52 Week Low
  • SLS $0.77
  • BRCC $1.19
  • 52 Week High
  • SLS $2.27
  • BRCC $3.85
  • Technical
  • Relative Strength Index (RSI)
  • SLS 52.67
  • BRCC 53.25
  • Support Level
  • SLS $1.69
  • BRCC $1.52
  • Resistance Level
  • SLS $2.01
  • BRCC $1.69
  • Average True Range (ATR)
  • SLS 0.11
  • BRCC 0.09
  • MACD
  • SLS 0.00
  • BRCC 0.01
  • Stochastic Oscillator
  • SLS 50.00
  • BRCC 62.50

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

Share on Social Networks: